Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The biggest highlight was Project Vimana, a drone-deployed battlefield trauma surgery system engineered to bring life-saving surgical intervention
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
Subscribe To Our Newsletter & Stay Updated
